SR
Sorrento Therapeutics, Inc.
SRNE · OTC
$0.00 +0.00% (+$0.00)
1M -42.86%
Market Cap $496.2K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.01x
PEG N/A
P/E N/A
Growth
100 /100
Growing Rev. growth 25.98%
Book val. growth N/A
EPS growth N/A
Profitability
19 /100
Weak Op. margin 802.55%
Gross margin 46.77%
FCF margin 489.37%
Quality
2 /100
Poor Asset turnover 0.13x
ROIC 286.80%
ROA 121.15%
Debt
50 /100
Moderate Net debt/EBITDA -0.21x
Current ratio 0.29x
Int. coverage -64.52x
Stability
50 /100
Moderate EPS volatility 31.57%
Beta 0.12x
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre SRNE
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Henry H. Ji
Employees
949
Headquarters
San Diego
Evenimente viitoare
06 NOV.
Earnings
Upcoming earnings report